ALLMedicine™ Eye Disorders Center

Jan 23rd, 2023 - To assess the relationship between sleep duration and the risk of major eye disorders including myopia, glaucoma, cataract, age-related macular degeneration (AMD), and diabetic retinopathy (DR). Databases including PubMed, Embase, Web of Science, ...

Jan 17th, 2023 - The primary objective is to assess the safety of intravitreal aflibercept injections in patients with wet age-related macular degeneration (wAMD), myopic choroidal neovascularization (mCNV), diabetic macular edema (DME), macular edema secondary to...

Jan 13th, 2023 - ADAMTS18 was identified in 2002 as a member of the ADAMTS family of 19 secreted Zinc-dependent metalloproteinases. Prior to 2016, ADAMTS18 was known as a candidate gene associated with a wide range of pathologies, particularly various malignancies...

Jan 4th, 2023 - Recent evidence has demonstrated that the global public health burden of myopia is rising rapidly. Highly myopic eyes are associated with increased frequency of eye disorders that can lead to irreversible visual impairment. With recent technologic...

Dec 29th, 2022 - There is accumulating evidence of the associations between age-related eye diseases (AREDs) and smoking or dietary factors. We aimed to provide an umbrella review of the published literature pertaining to smoking or dietary intake as risk factors ...

Jan 17th, 2023 - The primary objective is to assess the safety of intravitreal aflibercept injections in patients with wet age-related macular degeneration (wAMD), myopic choroidal neovascularization (mCNV), diabetic macular edema (DME), macular edema secondary to...

Dec 29th, 2022 - The National Eye Institute (NEI) is conducting a study to evaluate and provide standard treatment to participants with various diagnosed and undiagnosed ocular conditions. Objective: The primary objective of this protocol is to provide short term ...

Apr 30th, 2021 - The UK Biobank is a population-based study of a large prospective longitudinal cohort with information on 500,000 people, who were aged 40-69 when recruited in 2006-2010 from England, Scotland and Wales. The database includes demographic data, onl...

Dec 16th, 2019 - The National Eye Institute (NEI) is conducting a study to evaluate and provide standard treatment to participants with various diagnosed and undiagnosed ocular conditions. Objectives: The primary objective of this protocol is to provide a reservoi...

Jun 8th, 2017 - The DEAL (Diabetes En America Latina) study was a multicenter, cross-sectional, epidemiological, questionnaire based study carried out between October 2004 and October 2005 in 9 Latin American countries. General practitioners (GP) from private set...

Dec 5th, 2022 - The most comprehensive safety analysis of tralokinumab to date shows nothing unexpected in patients with atopic dermatitis (AD) treated for up to a year, according to a review published in the British Journal of Dermatology. Dr Eric Simpson These ...

Oct 21st, 2022 - The combination of encorafenib (Braftovi) and binimetinib (Mektovi) led to sustained improvements in progression-free survival (PFS) and overall survival (OS), without new safety signals in patients with BRAF V600–mutant melanoma, according to 5-y...

May 23rd, 2022 - Many Americans do not have access to a simple but life-changing device: eyeglasses. In a 2017 survey, nearly 1 in 10 Americans who reported needing glasses said they could not afford them. More than 2 million children in the United States also do ...

Oct 6th, 2021 - NEW YORK (Reuters Health) - A heightened risk of all-cause dementia was found to be associated with age-related macular degeneration (AMD), cataract and diabetes-related eye disease (DRED), but not glaucoma, according to data from the UK Biobank. ...

Sep 29th, 2021 - Health Canada has approved infigratinib (Truseltiq) for the treatment of adult patients with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma harboring a FGFR2 fusion or other rearrangement.1 The FGFR inhibitor...